Get the Stockscreener App
0.3507
9.61%
-0.0373
After Hours:
.37
0.0193
+5.50%
Kala Bio Inc stock is traded at $0.3507, with a volume of 573.56K.
It is down -9.61% in the last 24 hours and down -25.43% over the past month.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
See More
Previous Close:
$0.388
Open:
$0.391
24h Volume:
573.56K
Relative Volume:
0.08
Market Cap:
$319.60M
Revenue:
$5.75M
Net Income/Loss:
$-38.96M
P/E Ratio:
-0.0281
EPS:
-12.47
Net Cash Flow:
$-32.63M
1W Performance:
-14.51%
1M Performance:
-25.43%
6M Performance:
-97.66%
1Y Performance:
-94.98%
1-Day Range:
$0.349
$0.403
1-Week Range:
$0.349
$0.4181
52-Week Range:
$0.349
$20.60
Kala Bio Inc Stock (KALA) Company Profile
Name
Kala Bio Inc
Sector
Industry
Phone
781-996-5252
Address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
Compare KALA vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
0.3507 | 353.60M | 5.75M | -38.96M | -32.63M | -12.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.27 | 123.47B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
766.66 | 83.60B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
748.72 | 46.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
318.65 | 43.11B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
297.04 | 34.79B | 4.98B | 69.60M | 525.67M | 0.5198 |
Kala Bio Inc Stock (KALA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-30-25 | Downgrade | Mizuho | Outperform → Neutral |
| Sep-29-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Sep-29-25 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-08-25 | Initiated | Mizuho | Outperform |
| Jul-11-25 | Initiated | Ladenburg Thalmann | Buy |
| Mar-30-22 | Downgrade | JP Morgan | Neutral → Underweight |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-14-20 | Downgrade | Jefferies | Buy → Hold |
| Jul-23-20 | Initiated | Northland Capital | Outperform |
| Jun-01-20 | Resumed | Oppenheimer | Outperform |
| May-27-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-09-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-17-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-14-19 | Initiated | Jefferies | Buy |
View All
Kala Bio Inc Stock (KALA) Latest News
KALA BIO, Inc. (NASDAQ:KALA) Given Average Rating of "Hold" by Analysts - MarketBeat
KALA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Kala Bio (KALA) Stock Analysis Report | Financials & Insights - Benzinga Japan
Brendan P. Purdy Net Worth (2026) - GuruFocus
Hillel D. Posen Net Worth (2026) - GuruFocus
Comparing KALA BIO (NASDAQ:KALA) and Adagene (NASDAQ:ADAG) - Defense World
David Lazar resigns from KALA BIO board - TradingView
Why KALA BIO Inc. stock could benefit from AI revolutionQuarterly Portfolio Report & Smart Allocation Stock Tips - mfd.ru
Can KALA BIO Inc. withstand a market correction2025 Major Catalysts & Advanced Technical Analysis Signals - mfd.ru
MSN Money - MSN
KALA.O PE Ratio & Valuation, Is KALA.O Overvalued - Intellectia AI
KALA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Can KALA BIO Inc. outperform under higher oil pricesRecession Risk & Weekly Hot Stock Watchlists - mfd.ru
Can KALA BIO Inc. be the next market leader2025 Winners & Losers & AI Powered Trade Plan Recommendations - mfd.ru
Market Catalysts: Is KALA BIO Inc part of any major indexQuarterly Performance Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
KALA to Offer 241.44 Million Shares in New Stock Sale - GuruFocus
Macro Review: Can KALA BIO Inc stock outperform in a bear market2025 Buyback Activity & Reliable Price Action Trade Plans - baoquankhu1.vn
KALA BIO (KALA) names director Avi Minkowitz CEO and CFO as David Lazar steps down - Stock Titan
Bearish Setup: Can Arm Holdings plc Depositary Receipt outperform under higher oil pricesRate Hike & Scalable Portfolio Growth Methods - baoquankhu1.vn
KALA BIO expands preferred financing and shareholder authorizations - The Globe and Mail
KALA BIO Signs Securities Purchase Agreement With Series AAA Investors - TradingView
KALA: All proposals, including director elections and share increases, passed with no stockholder questions - TradingView
KALA: All proposals, including director elections and share increase, passed unanimously - TradingView
KALA BIO Receives Nasdaq Notice on Listing Compliance - The Globe and Mail
KALA Bio Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Aug EndMonth: Is Codere Online Luxembourg SAs ROIC above industry averagePortfolio Performance Summary & Daily Stock Trend Watchlist - baoquankhu1.vn
Trading Action: Can LOAN weather a recessionTrade Risk Report & Low Risk Entry Point Tips - baoquankhu1.vn
KALA Stock Price, Forecast & Analysis | KALA BIO INC (NASDAQ:KALA) - Chartmill
Can KALA BIO Inc stock outperform in a bear marketWeekly Profit Analysis & Breakout Confirmation Trade Signals - baoquankhu1.vn
Why KALA BIO Inc stock is a must watch in 2025July 2025 PostEarnings & Community Driven Trade Alerts - Bộ Nội Vụ
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Kala Bio Stock Sinks On CEO Exit, But Retail Feels It’s An Overreaction - MSN
KALA BIO Inc. (KALA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
KALA BIO Launches At-the-Market Equity Offering Program - TipRanks
Why hedge funds are buying KALA BIO Inc. stockPortfolio Growth Summary & Risk Adjusted Swing Trade Ideas - Улправда
Can KALA BIO Inc. stock weather global recessionJuly 2025 Final Week & Real-Time Chart Breakout Alerts - Улправда
KALA BIO eliminates debt overhang through equity settlements - TipRanks
KALA BIO Signs Multiple Material Agreements - TradingView — Track All Markets
KALA BIO Clears Oxford DebtA Fresh Start Ahead? - Nasdaq
Kala Bio Settles $10.6 Million Debt; Shares Rise After-Hours - MarketScreener
Kala Bio settles $10.6 million debt with Oxford Finance By Investing.com - Investing.com Nigeria
Kala Bio Settles Approximately $10.6 Million Of Debt - TradingView — Track All Markets
Kala Bio settles $10.6 million debt with Oxford Finance - Investing.com
KALA BIO Settles Approximately $10.6 million of Debt - The Manila Times
Kala Bio fully settles loan, strengthens balance sheet - MSN
Kala Bio Inc pays $2 million to Oxford Finance LLC as part of settlement agreement - marketscreener.com
KALA BIO Announces Conditional Resignations of Six Directors - TradingView — Track All Markets
KALA BIO Directors Plan Conditional Resignations Tied to Vote - TipRanks
Top Penny Stocks To ResearchDecember 4th - MarketBeat
Why Did Indaptus Therapeutics Surge 64% In After-Hours Trading? - Benzinga
Support Test: What insider trading reveals about AAOI stockJuly 2025 Sentiment & High Return Trade Guides - moha.gov.vn
Kala Bio Inc Stock (KALA) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.71%
0.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):